ARCH Venture Fund X, L.P. — insider trades

Stock trades ARCH Venture Fund X, L.P. reported on SEC Form 4 at NMRA Neumora Therapeutics, Inc., PRME Prime Medicine, Inc..

• Oct 27, 2025: bought 1,915,700 shares of NMRA Neumora Therapeutics, Inc. ($5.00M)
• Aug 1, 2025: bought 3,030,300 shares of PRME Prime Medicine, Inc. ($10.00M)